10.6084/m9.figshare.c.3783488_D4.v1 Virginie Nägele Virginie Nägele Andrea Kratzer Andrea Kratzer Gerhard Zugmaier Gerhard Zugmaier Chris Holland Chris Holland Youssef Hijazi Youssef Hijazi Max Topp Max Topp Nicola Gökbuget Nicola Gökbuget Patrick Baeuerle Patrick Baeuerle Peter Kufer Peter Kufer Andreas Wolf Andreas Wolf Matthias Klinger Matthias Klinger MOESM4 of Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL Springer Nature 2017 Acute lymphoblastic leukemia Blinatumomab Bispecific BiTE® CD19 Liver enzymes Pharmacodynamics 2017-05-18 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/MOESM4_of_Changes_in_clinical_laboratory_parameters_and_pharmacodynamic_markers_in_response_to_blinatumomab_treatment_of_patients_with_relapsed_refractory_ALL/5024294 Additional file 4. Available patient numbers (N) for analysis of distribution profiles of CD8+ and CD4+ T cells and subsets in Fig. 4.